Novel Self-Nano-Emulsifying Drug Delivery Systems Containing Astaxanthin for Topical Skin Delivery

Astaxanthin (ASX) is a potent lipophilic antioxidant derived from the natural pigment that gives marine animals their distinctive red-orange colour and confers protection from ultraviolet radiation. Self nano-emulsifying drug delivery systems (SNEDDS) have been successfully developed and evaluated to increase the skin penetration of ASX and target its antioxidant and anti-inflammatory potential to the epidermis and dermis. SNEDDS were prepared using a low-temperature spontaneous emulsification method, and their physical characteristics, stability, antioxidant activity, and skin penetration were characterized. Terpenes (D-limonene, geraniol, and farnesol) were included in the SNEDDS formulations to evaluate their potential skin penetration enhancement.

An HPLC assay was developed that allowed ASX recovery from skin tissues and quantification. All SNEDDS formulations had droplets in the 20 nm range, with low polydispersity. ASX stability over 28 days storage in light and dark conditions was improved and antioxidant activity was high. SNEDDS-L1 (no terpene) gave significantly increased ASX penetration to the stratum corneum (SC) and the epidermis-dermis-follicle region (E + D + F) compared to an ASX in oil solution and a commercial ASX facial serum product.

The SNEDDS-containing D-limonene gave the highest ASX permeation enhancement, with 3.34- and 3.79-fold the amount in the SC and E + D + F, respectively, compared to a similar applied dose of ASX in oil. We concluded that SNEDDS provide an effective formulation strategy for enhanced skin penetration of a highly lipophilic molecule, and when applied to ASX, have the potential to provide topical formulations for UV protection, anti-aging, and inflammatory conditions of the skin.

Download the full article here: Novel Self-Nano-Emulsifying Drug Delivery Systems Containing Astaxanthin for Topical Skin Delivery

or continue reading here: Ponto, T.; Latter, G.; Luna, G.; Leite-Silva, V.R.; Wright, A.; Benson, H.A.E. Novel Self-Nano-Emulsifying Drug Delivery Systems Containing Astaxanthin for Topical Skin Delivery. Pharmaceutics 2021, 13, 649.

Astaxanthin of analytical grade (CAS# 472-61-7) (SML0982) with a purity of 99.7%, Kolliphor® EL (Polyoxyl 35 castor oil–CAS# 61791-12-6), D-limonene (CAS# 5989-27-5), geraniol (CAS# 106-24-1), farnesol (CAS# 4602-84-0), L-ascorbic acid (CAS# 50-81-7), potassium persulfate (CAS# 7727-21-1), and ABTS (Roche-Diagnostics GmbH) (CAS# 30931-67-0) were purchased from Sigma-Aldrich (North Ryde, Australia). Labrafil® M 1944 CS (Oleoyl polyoxyl-6 glycerides–CAS# 69071-70-1) and Transcutol® P (Ethoxydiglycol–CAS# 111-90-0) were kind gifts from Gattefossé (Saint-Priest, France). Astarism® facial serum was a gift from AstaREAL Co. Ltd., Minato-ku, Tokyo, Japan. Veet™ hair removal cream (containing potassium thioglycolate) was purchased from Reckitt Benckiser Pty Ltd. (Sydney, Australia). HPLC-grade methanol and ethanol were from Thermo Fisher Scientific (Scoresby, Australia). HPLC-grade solvents (including acetone (ACT) and dichloromethane (DCM) were purchased from RCI Labscan Ltd. (Pathumwan, Bangkok, Thailand) distributed by Chem-Supply Pty Ltd., Gillman, Australia. Potassium chloride and sodium chloride were purchased from Chem-Supply Australia Pty Ltd. Potassium dihydrogen orthophosphate was purchased from Thermo Fisher Scientific (Scoresby, Australia). Di-sodium hydrogen orthophosphate anhydrous was purchased from Merck Pty Ltd (Bayswater, Australia). Deionised water was produced using a Milli-Q RC apparatus (Millipore Corporation, Bedford, MA, USA).

You might also like